PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
10-May-2022 Recuro Health Awarded as Technology Pioneer by World Economic Forum Businesswire
10-May-2022 Growing Number Of Organ Donors to Create Demand For Organ Care Markets by 2031 MARKITWIRED Latest Market Reports
10-May-2022 Unhealthy Lifestyle is Major Factor to Boost the Demand for Intravenous Solutions during 2021 to 2031 MARKITWIRED Latest Market Reports
10-May-2022 The Higher Rates of New Cancer Diagnoses Are Expected to Drive the Demand for Intravascular Catheters Market MARKITWIRED Latest Market Reports
10-May-2022 Rapid Microbiological Method (RMM) is Likely to Influence the Bioburden Testing Demand During The Forecast Period (2021-2031) MARKITWIRED Latest Market Reports
10-May-2022 FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets Businesswire
10-May-2022 Sygnature Discovery to Deploy Iktos’s AI for Drug Design Software Makya™ Businesswire
10-May-2022 Demand For Laboratory Informatics Market Is Likely To Increase By 2021 To 2031 MARKITWIRED Latest Market Reports
10-May-2022 Roche pledges to extend commitment to the World Federation of Hemophilia Humanitarian Aid Program to 2028 Roche
10-May-2022 MODERNA TO HOST ANNUAL SCIENCE AND TECHNOLOGY DAY ON MAY 17, 2022 MODERNA
10-May-2022 Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi® (solriamfetol) to Axsome Therapeutics Jazz Pharmaceuticals
10-May-2022 UCB presents efficacy and safety results for zilucoplan and rozanolixizumab in generalized myasthenia gravis UCB
10-May-2022 Kaiku Health enters a strategic partnership to further improve patient outcomes through digital patient monitoring Kaiku Health
10-May-2022 AlzeCure presents the science behind NeuroRestore and TrkA-NAM at drug development conference AlzeCure
10-May-2022 Publication of Annual Financial Report Spectral MD Holdings, Ltd
10-May-2022 Moberg Pharma´s Interim report January - March 2022 Moberg Pharma
10-May-2022 Moberg Pharma begins patient enrollment in North American phase 3 study Moberg Pharma
10-May-2022 Three Rising Trends In Dental Chair Market Over 2022-2028 Global Market Insights
10-May-2022 FORXIGA (DAPAGLIFLOZIN) ACCEPTED FOR USE IN SCOTLAND FOR THE TREATMENT OF ADULT PATIENTS WITH CHRONIC KIDNEY DISEASE AstraZeneca
10-May-2022 NHS Scotland first in the UK to approve JYSELECA®▼ (filgotinib) for a form of Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC) Galapagos UK